8-K - Kiniksa Pharmaceuticals, Ltd. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

. Results of Operations and Financial Condition On January 12, 2026, Kiniksa Pharmaceuticals International, plc (the “Company”) issued a press release announcin

Financial Results

$677.5M$414.1M

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by Kiniksa Pharmaceuticals International

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1